Pyrroloquinolin compounds and methods of using same
US11020488B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 13, 2018 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Mar 13, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are pyrroloquinolin compounds of formula (1) or (II). In certain aspects, the pyrroloquinolin compounds are therapeutic, e.g., for treating a cell proliferative disorder. Also provided are conjugates that include the pyrroloquinolin compounds of the present disclosure. Compositions, e.g., pharmaceutical compositions, that include the pyrroloquinolin compounds and conjugates of the present disclosure are also provided. Further provided are therapeutic methods involving the administration of the pyrroloquinolin compounds, conjugates or compositions of the present disclosure. Kits that include the pyrroloquinolin compounds, conjugates or compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.